Sandu Pharmaceuticals Limited announced that at the board meeting held on March 30, 2024, the company considered and appointed CA Shri Balram Viswanathan Non Executive Independent Director, as Chairman of the Board. Considered and took note of the below mentioned Retiring Non Executive Independent Director after completion of 02nd terms of 05 years tenure at closure of Business hour i.e March 31, 2024. A. Shri K Vinay Kumar, B. Shri Dilip Salgaocar, C. Shri Dr. Madan Kapre, D. Shri Dr. Krishna Deshpande. Considered and approved Reconstitution of Audit Committee, Nomination and
Remuneration Committee and Stakeholder Relationship Committee. Audit Committee:- CA Shri Balram Viswanathan, Shri Adv Ajit Kantak, Shri Umesh B Sandu. Nomination and Remuneration Committee:- Adv Shri Ajit Kantak, CA Shri Balram Viswanathan, Shri Shashank B Sandu. Stakeholders Relationship Committee:- Shashank B Sandu, Ajit Kantak,Umesh B Sandu. CA Shri Balram is BCOM, FCA, CPA(USA) and has expertise in Audit, Tax, M&A Advisory, Due Diligence, Compliance and Valuation services along with financial control, planning & analysis, regulatory reporting, business strategy, treasury and risk management experience gained in large International Banks. He has previously worked in senior roles viz. CFO International Banking Group at National Bank of Kuwait, Chief Finance and Operating officer at Gulf Finance Dubai, UAE, Country Head of Finance at Al Ahli Bank of Kuwait in Dubai, UAE, Vice President Financial reporting and Group Risk control at Deutsche Bank in India and as a Senior Auditor at Ernst & Young in India. . He has a vast and varied experience having engaged in audit of clients in manufacturing, trading health, Hotels and food & beverages, real estate contracting and construction companies, oil and gas holding companies telecommunications, banking and other sectors. Having dealt with regulators across the GCC, Federal Reserve, FSA and MAS, he is well experienced in the areas of Corporate Governance and Risk Management, International Auditing Standards.